StemCells, Inc. (Nasdaq: STEM), announced preclinical data demonstrating that its proprietary human neural stem cells restored memory and enhanced synaptic ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE